Exosens Surges Past 2025 Targets on Defense Demand, Eyes €1 Billion Revenue
Event summary
- Exosens reported €468.2 million in 2025 revenue, up 22.1% year-over-year, driven by strong Defense & Surveillance demand.
- Defense and Surveillance accounted for 75% of 2025 revenue, with Amplification revenue growing 18.4% and Detection & Imaging up 28%.
- Adjusted EBITDA margin hit a record 32.4%, with net profit from continued operations doubling to €70.2 million.
- Exosens completed three acquisitions in 2025 (Noxant, NVLS, Phasics) and divested its Microwave Amplifier business.
- The company plans to expand production capacity by 40% by 2027, targeting €1 billion in revenue.
The big picture
Exosens' strong 2025 performance underscores the growing demand for advanced imaging and night vision technologies in defense applications. The company's strategic focus on high-value Defense & Surveillance markets, coupled with disciplined M&A and capacity expansion plans, positions it to capitalize on long-term structural growth trends. However, sustaining this momentum will require navigating geopolitical uncertainties and execution risks in its ambitious expansion initiatives.
What we're watching
- Defense Demand Sustainability
- Whether Exosens can maintain its strong Defense & Surveillance growth amid evolving geopolitical tensions and budget priorities.
- Capacity Expansion Risks
- The pace at which Exosens can execute its 40% production capacity expansion without operational bottlenecks or cost overruns.
- M&A Strategy Impact
- How the integration of recent acquisitions (Noxant, NVLS, Phasics) will affect Exosens' profitability and market positioning.
Related topics